Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page
- Check2 days agoChange DetectedA MedlinePlus Genetics resource link for melanoma appears among the study’s related health-information links.SummaryDifference0.2%

- Check9 days agoChange DetectedThe study record for PV-10 combined with pembrolizumab in metastatic melanoma is available, including its phase 1b/2 design, eligibility criteria, treatment arms, outcomes, and five U.S. locations.SummaryDifference51%

- Check16 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide banner announces an NIH website transition and says the agency is adopting “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check30 days agoChange DetectedThe site revision label on the 403 Forbidden page changed from v3.7.1 to v3.7.2; the study record remains unavailable.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.